Анализ уровня интерлейкина-6 и полиморфизма G-174C гена интерлейкина-6 у пациентов с неклапанной фибрилляцией предсердий

Д.А. Бубешко, В.А. Снежицкий, Т.Л. Степуро УО «Гродненский государственный медицинский университет»

2017 №2 | Оригинальные научные публикации

Аннотация

Список литературы

Цель исследования: изучить уровень интерлейкина-6 (ИЛ-6), распределение частот аллелей и генотипов полиморфного варианта G-174C гена ИЛ-6 у пациентов Гродненского региона, а также оценить их взаимосвязь с развитием неклапанной фибрилляции предсердий (ФП).

Ключевые слова:

фибрилляция предсердий, систолическая дисфункция левого желудочка, интерлейкин-6, полиморфизм G-174C гена интерлейкина-6

Analisis of interleukin-6 level and polymorphism G-174C of gene IL-6 in patients with nonvalvular atrial fibrillation

The purpose of research to study interleukin-6 (IL-6) plasma level, the distribution of genotypes and allele frequencies of the polymorphic marker G-174C of gene IL-6 in patients of the Grodno region and to evaluate their relationship with risk of atrial fibrillation development.

Keywords

atrial fibrillation, left ventricular systolic dysfunction, interleukin -6, polymorphism G-174C of gene IL-6

1. Снежицкий, В.А. Роль воспаления в патогенезе фибрилляции предсердий / В. А. Снежицкий, Д. А. Бубешко // Кардиология в Беларуси. – 2015. – Т. 41, № 4. – С. 129 – 138.
2. Cover image serum interleukin-6 and C-reactive protein are markedly elevated in acute decompensated heart failure patients with left ventricular systolic dysfunction / M. Matsumotoa [et al.] // Cytokine. – 2010. – Vol. 49, N 3. – P. 264 – 268.
3. Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction / R. J. Raymond [et al.] // Am. Heart J. – 2001. – Vol. 141, N 3. – P. 435 – 438.
4. High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation / V. Roldán [et al.] // Journal of Thrombosis and Haemostasis. – 2012. – Vol. 10, N 8. – P. 1500 – 1507.
5. Il-6 switches the differentiation of monocytes from dendritic cells to macrophages / P. Chomarat [et al.] // Nat. Immunol. – 2000. – Vol. 1. – P. 510 – 514.
6. Interleukin 6 promoter polymorphisms in normal Han Chinese population: frequencies and effects on inflammatory markers / M. Pan [et al.] // J. Investig. Med. – 2011. – Vol. 59, N 2. – P. 272 – 276.
7. Interleukin-6 and atrial fibrillation in patients with coronary artery disease; data from the Heart and Soul Study / G. M. Marcus [et al.] // Am. Heart. J. – 2008. – Vol. 155. – P. 303 – 309.
8. Interleukin-6 is a risk factor for atrial fibrillation in chronic kidney disease: findings from the CRIC study / R. L. Admur [et al.] // PLOS ONE. – 2016. – Vol. 11, N 2. – P. 1 – 12.
9. Interleukin-6 Promoter Polymorphisms and Susceptibility to Atrial Fibrillation in Elderly Han Chinese Patients with Essential Hypertension / L. Jing [et al.] // Journal of interferon & cytokine research. – 2012. – Vol. 32, N 11. – P. 542 – 547.
10. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD) / G. Torre-Amione [et al.] // J. Am. Coll. Cardiol. – 1996. – Vol. 27. – P. 1201 – 1206.
11. Relation of the -174 G/C polymorphism of interleukin-6 to interleukin-6 plasma levels and to length of hospitalization after surgical coronary revascularization / F. Burzotta [et al.] // Am. J. Cardiol. – 2001. – Vol. 88. – P. 1125 – 1128.
12. Relationship of interleukin-6 with regional and global left-ventricular function in asymptomatic individuals without clinical cardiovascular disease: insights from the Multi-Ethnic Study of Atherosclerosis / A. T. Yan [et al.] // Eur. Heart. J. – 2010. – Vol. 31, N 7. – P. 875 – 882.
13. Stromelysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis / R. Rauramaa [et al.] // Arterioscler. Thromb. Vasc. Biol. – 2000. – Vol. 20. – P. 2657 – 2662.
14. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis / D. Fishman [et al.] // J. Clin. Invest. – 1998. – Vol. 102. – P. 1369 – 1376.
15. The interleukin-6G (−174) C promoter polymorphism in the LURIC cohort: no association with plasma interleukin-6 coronary artery disease and myocardial infarction / M. Nauck [et al.] // J. Mol. Med. – 2002. – Vol. 80. – P. 507 – 513.